KFA
ABBV icon

Kabarec Financial Advisors’s AbbVie ABBV Stock Holding History

Kabarec Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-6,582
Closed -$623K – 83
2018
Q1 		$623K Buy
6,582
+4
+0.1% +$439 0.39% 28
2017
Q4 		$636K Buy
+6,578
New +$620K 0.39% 30

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Kabarec Financial Advisors's ABBV Position: Q2 2018 in Review

Kabarec Financial Advisors sold out of AbbVie (ABBV) in Q2 2018, closing a stake of 6,582 shares — an estimated $623K sold.

Kabarec Financial Advisors first reported a position in ABBV in Q4 2017 and held it in 2 quarters. The position peaked at $636K in Q4 2017. 1,996 funds tracked by Wall St. Rank hold ABBV as of Q2 2018.

  • Kabarec Financial Advisors reported no remaining AbbVie position as of Q2 2018 after selling out during the quarter.
  • Kabarec Financial Advisors sold 6,582 AbbVie shares in Q2 2018, an estimated $623K.
  • Kabarec Financial Advisors first reported a position in AbbVie in Q4 2017 and held it in 2 quarters.
  • Kabarec Financial Advisors's AbbVie position peaked at $636K in Q4 2017.
  • 1,996 funds tracked by Wall St. Rank held AbbVie as of Q2 2018.

Based on Kabarec Financial Advisors's 13F filing for Q2 2018, filed 9 Aug 2018.